Goldman Sachs Call 180 VIFN 20.03.../ DE000GA6DTT2 /

12/13/2019 12:23:04 PM	Chg.-0.040	Bid9:54:28 PM	Ask9:54:28 PM	Underlying	Strike price	Expiration date	Option type
0.550EUR	-6.78%	0.580 Bid Size: 11,000	0.650 Ask Size: 11,000	VIFOR N	180.00 CHF	3/20/2020	Call

Newsfile Corp 11/27 NervGen Pharma Appoints Paul Brennan as President & Chief Executive Officer

GlobeNewswire 11/26 ChemoCentryx to Present at the 31st Annual Piper Jaffray Healthcare Conference

GlobeNewswire 11/25 ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonst...

GlobeNewswire 11/5 Cara Therapeutics Reports Third Quarter 2019 Financial Results

GlobeNewswire 11/5 Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Com...

GlobeNewswire 11/4 ChemoCentryx Reports Third Quarter 2019 Financial Results and Recent Highlights

GlobeNewswire 11/4 Santhera Appoints New Chief Executive Officer

GlobeNewswire 9/24 ChemoCentryx to Host R&D Day on October 1, 2019

GlobeNewswire 8/29 ChemoCentryx to Present at Two Upcoming Investor Conferences

GlobeNewswire 8/7 OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results

GlobeNewswire 8/7 Cara Therapeutics Reports Second Quarter 2019 Financial Results

GlobeNewswire 8/5 ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights

GlobeNewswire 8/1 ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference

GlobeNewswire 7/31 ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019

GlobeNewswire 7/15 Adverum Biotechnologies Appoints Senior Leaders

GlobeNewswire 6/11 ChemoCentryx to Present at Two Upcoming Investor Conferences

GlobeNewswire 5/29 Global IV and Oral Iron Drugs Markets 2019-2024 - Investigational Iron Drugs and Expected Approvals ...

GlobeNewswire 5/14 CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A F...

GlobeNewswire 5/7 OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results

GlobeNewswire 5/7 Cara Therapeutics Reports First Quarter 2019 Financial Results

GlobeNewswire 5/7 Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association

GlobeNewswire 5/6 ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights

GlobeNewswire 4/30 Global Chronic Kidney Disease Markets and Technologies Through 2023

GlobeNewswire 4/29 ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019

GlobeNewswire 4/26 Anemia Treatment Drugs: 2019 Global Market Study; Analyzed by Type of Anemia, Type of Drug, and Geog...